Immunic, Inc.

IMUX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Oct 1, 2026
4 Sep 18, 2026
4 Sep 18, 2026 OWNERSHIP DOCUMENT
8-K Sep 11, 2026
8-K Sep 9, 2026
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
S-8 Aug 12, 2026
8-K Aug 11, 2026
10-Q Aug 11, 2026 10-Q
4 Aug 10, 2026
3 Aug 10, 2026
SCHEDULE 13G/A Aug 6, 2026
SCHEDULE 13G Aug 4, 2026
SCHEDULE 13G/A Jul 16, 2026
8-K Jul 14, 2026
4 Jul 7, 2026
4 Jul 7, 2026
4 Jul 7, 2026
4 Jul 7, 2026
4 Jul 7, 2026
8-K Jul 6, 2026
4 Jun 29, 2026
← Newer Page 1 of 34 · 830 filings Older →